Loading clinical trials...
Loading clinical trials...
Plasma Biomarkers in Stratifying Patients Referred Via the Lower Gastro-intestinal (LGI) Suspected Cancer Two-week Wait (2WW) Pathway
Conditions
Locations
1
United Kingdom
Barts Health NHS Trust
London, England, United Kingdom
Start Date
June 30, 2025
Primary Completion Date
July 1, 2026
Completion Date
October 1, 2026
Last Updated
August 8, 2025
NCT03050268
NCT07541924
NCT05969860
NCT04693377
NCT07146165
NCT05863195
Lead Sponsor
Queen Mary University of London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions